Robotic versus laparoscopic colorectal surgery for people with IBD

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, single-center trial will enroll 110 adults with inflammatory bowel disease who require elective minimally invasive colorectal resections and assign them to either multiport robotic or conventional laparoscopic surgery. Both approaches are minimally invasive and commonly used in practice; outcomes include surgical complications, recovery metrics, pain (VAS during the first three days), and quality-of-life questionnaires completed before surgery and at 30 and 90 days. The trial directly compares postoperative complication rates and patient-reported recovery between the two surgical techniques. All procedures and follow-up are conducted at University Hospitals Leuven.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
2. At least 18 years of age at the time of signing the Informed Consent Form (ICF)
3. Diagnosed with IBD and eligible for elective minimally invasive colorectal surgery, including:

   1.4 Ileocecal/ileocolic resections 1.5 Segmental colectomies 1.6 Total colectomy 1.7 Proctocolectomy 1.8 Proctectomy
4. Procedures involving primary anastomosis or temporary or permanent stoma creation
5. Suitable for minimally invasive surgery

Exclusion Criteria:

1. Non IBD patients
2. Urgent surgery (\<24 hours from hospital admission)
3. Not suitable for minimally invasive surgery
4. Ileoanal pouch construction

Where it's running

• Abdominal Surgery
  Leuven, Vlaams Brabant, Belgium Recruiting

Study contacts

• Principal investigator: Gabriele Bislenghi, Professor — UZ Leuven
• Study coordinator: Isabelle Terrasson
• Email: isabelle.terrasson@uzleuven.be
• Phone: +3216340837

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Maternal and infant microbiome links to infant gut inflammation and pregnancy outcomes in people with IBD

  This project will see if mothers' microbiomes, diets, and breastmilk are linked to infant gut inflammation (measured by fecal calprotectin) in pregnant people with and without IBD.

  Recruiting University of British Columbia · Vancouver, British Columbia and 1 other locations · NCT07385807

• Infliximab plus the Crohn's Disease Exclusion Diet for children with Crohn's disease

  This will test whether starting a Crohn's Disease Exclusion Diet at the same time as infliximab helps children with moderate-to-severe Crohn's disease get better and stay in remission.

  Recruiting University of British Columbia · Vancouver, British Columbia · NCT07314606

• SMART-IBD app for teens with inflammatory bowel disease

  This will test whether the SMART-IBD smartphone app helps adolescents ages 13–17 with IBD take their medicines and manage symptoms better than completing daily diaries alone.

  Recruiting Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT07195123

• Melatonin to improve sleep quality in adults with inflammatory bowel disease in remission

  This study tests whether melatonin can improve sleep quality in adults with IBD who are in clinical remission.

  Recruiting Phase 4 Mahidol University · Bangkok Noi, Bangkok · NCT07737665

• Individualizing Anti-TNF Therapy in IBD

  This study tests whether genetic markers can predict which anti-TNF–naïve IBD patients will respond to their first anti-TNF treatment.

  Recruiting Tel-Aviv Sourasky Medical Center · Tel Aviv · NCT07644117

• BDHK-2009 safety test in healthy adults

  This early-stage test checks if BDHK-2009 tablets are safe and tolerable in healthy adults aged 18–55 compared with placebo.

  Recruiting Phase 1 Benethera (Shaoxing) Biotechnology Co., Ltd. · Hangzhou, Zhejiang · NCT07632573

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.